Dan Neal

Dan Neal

Auto-generated profile, based on publicly available information

Dan Neal

Department of Surgery, University of Florida, Gainesville, FL

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2024 in Circulation: Cardiovascular Quality and Outcomes
Verified
Journal Article
Closed access
BGBrian F. Gilmore
Brian F. Gilmore
SSSalvatore T. Scali
Salvatore T. Scali
Mario D’OriaMario D’Oria
Mario D’Oria
DNDan Neal
Dan Neal
MSMarc L. Schermerhorn
Marc L. Schermerhorn
DSDavid H. Stone
David H. Stone
BACKGROUND: Endovascular aortic aneurysm repair (EVAR) has had a dynamic impact on abdominal aortic aneurysm (AAA) care, often supplanting open AAA repair (OAR). Accordingly, US AAA management is often highlighted by disparities in patient selection and guideline compliance. The purpose of this analysis was to define secular trends in AAA care. METHODS: The Society for Vascular Surgery Vascular Quality Initiative was queried for all EVARs and OARs (2011–2021). End points included procedure utilization, change in mortality, patient risk profile, Society for Vascular Surgery-endorsed diameter compliance, off-label EVAR use, cross-clamp location, blood loss, in-hospital complications, and post-EVAR surveillance missingness. Linear regression was used without risk adjustment for all end points except for mortality and complications, for which logistic regression with risk adjustment was used. RESULTS: In all, 66 609 EVARs (elective, 85% [n=55 805] and nonelective, 15% [n=9976]) and 13 818 OARs (elective, 70% [n=9706] and nonelective, 30% [n=4081]) were analyzed. Elective EVAR:OAR ratios were increased (0.2 per year [95% CI, 0.01–0.32]), while nonelective ratios were unchanged. Elective diameter threshold noncompliance decreased for OAR (24%→17%; P =0.01) but not EVAR (mean, 37%). Low-risk patients increasingly underwent elective repairs (EVAR, +0.4%per year [95% CI, 0.2–0.6]; OAR, +0.6 points per year [95% CI, 0.2–1.0]). Off-label EVAR frequency was unchanged (mean, 39%) but intraoperative complications decreased (0.5% per year [95% CI, 0.2–0.9]). OAR complexity increased reflecting greater suprarenal cross-clamp rates (0.4% per year [95% CI, 0.1–0.8]) and blood loss (33 mL/y [95% CI, 19–47]). In-hospital complications decreased for elective (0.7% per year [95% CI, 0.4–0.9]) and nonelective EVAR (1.7% per year [95% CI, 1.1–2.3]) but not OAR (mean, 42%). A 30-day mortality was unchanged for both elective OAR (mean, 4%) and EVAR (mean, 1%). Among nonelective OARs, an increase in both 30-day (0.8% per year [95% CI, 0.1–1.5]) and 1-year mortality (0.8% per year [95% CI, 0.3–1.6]) was observed. Postoperative EVAR surveillance acquisition decreased (67%→49%), while 1-year mortality among patients without imaging was 4-fold greater (9.2% versus imaging, 2.0%; odds ratio, 4.1 [95% CI, 3.8–4.3]; P <0.0001). CONCLUSIONS: There has been an increase in EVAR and a corresponding reduction in OAR across the United States, despite established concerns surrounding guideline adherence, reintervention, follow-up, and cost. Although EVAR morbidity has declined, OAR complication rates remain unchanged and unexpectedly high. Opportunities remain for improving AAA care delivery, patient and procedure selection, guideline compliance, and surveillance.

13 February 2024 in Journal of Vacuum Science & Technology B
Verified
Journal Article
Open access
PDF file
HSIAO-HSUAN WANHSIAO-HSUAN WAN
HSIAO-HSUAN WAN
HZHaochen Zhu
Haochen Zhu
CCChao-Ching Chiang
Chao-Ching Chiang
JLJian-Sian Li
Jian-Sian Li
FRFan Ren
Fan Ren
SPStephen Pearton
Stephen Pearton
The prevalence of breast cancer in women underscores the urgent need for innovative and efficient detection methods. This study addresses this imperative by harnessing salivary biomarkers, offering a noninvasive and accessible means of identifying breast cancer. In this study, commercially available disposable based strips similar to the commonly used glucose detection strips were utilized and functionalized to detect breast cancer with biomarkers of HER2 and CA15-3. The results demonstrated limits of detection for these two biomarkers reached as low as 1 fg/ml much lower than those of conventional enzyme-linked immunosorbent assay in the range of 1∼4 ng/ml. By employing a synchronized double-pulse method to apply 10 of 1.2 ms voltage pulses to the electrode of sensing strip and drain electrode of the transistor for amplifying the detected signal, and the detected signal was the average of 10 digital output readings corresponding to those 10 voltage pulses. The sensor sensitivities were achieved approximately 70/dec and 30/dec for HER2 and CA15-3, respectively. Moreover, the efficiency of this novel technique is underscored by its swift testing time of less than 15 ms and its minimal sample requirement of only 3 μl of saliva. The simplicity of operation and the potential for widespread public use in the future position this approach as a transformative tool in the early detection of breast cancer. This research not only provides a crucial advancement in diagnostic methodologies but also holds the promise of revolutionizing public health practices.

26 August 2022 in Surgery
Verified
Journal Article
Closed access
PHPhilip Kyung Woo Hong
Philip Kyung Woo Hong
JSJuan Pablo Santana
Juan Pablo Santana
SLShawn D. Larson
Shawn D. Larson
ABAmy M. Berger
Amy M. Berger
LILauren A. Indelicato
Lauren A. Indelicato
RPRobin T. Petroze
Robin T. Petroze

24 January 2022 in Journal of Surgical Research
Verified
Journal Article
Closed access
JDJames R. Davis
James R. Davis
ANAlice Nsengiyumva
Alice Nsengiyumva
DIDeborah Igiraneza
Deborah Igiraneza
PHPhilip Hong
Philip Hong
RURosine Umutoni
Rosine Umutoni
ENEdmond Ntaganda
Edmond Ntaganda

26 September 2022 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
PHPhilip Kyung Woo Hong
Philip Kyung Woo Hong
JSJuan Pablo Santana
Juan Pablo Santana
SLShawn D. Larson
Shawn D. Larson
ABAmy Berger
Amy Berger
MMMoiz M. Mustafa
Moiz M. Mustafa
RPRobin T. Petroze
Robin T. Petroze

15 June 2023 in Pancreatology
Verified
Journal Article
Closed access
KHKelly Herremans
Kelly Herremans
PUPatirck Underwood
Patirck Underwood
ARAndrea Nicole Riner
Andrea Nicole Riner
DNDaniel W. Neal
Daniel W. Neal
GTGerik W. Tushoski-Alemán
Gerik W. Tushoski-Alemán
SHSteven J. Hughes
Steven J. Hughes